• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 5 of 100
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
FinanceVietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By AFPMarch 27, 2025
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
TechSanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By Ryan HoggMarch 27, 2025
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
Tech‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By Ryan HoggMarch 25, 2025
AstraZeneca to buy cell therapy biotech for up to $1 billion
TechAstraZeneca to buy cell therapy biotech for up to $1 billion
By Ashleigh Furlong and BloombergMarch 17, 2025
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
CommentaryMy son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
By Michelle WernerMarch 10, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
CommentaryThe crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up
By Wendy BarnesMarch 4, 2025
Anne Wojcicki on stage at a conference
LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025
Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.
HealthGSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By Ryan HoggFebruary 28, 2025
Eli Lilly's headquarters sits behind a gate with the US flag raised
FinanceEli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom
By Madison Muller and BloombergFebruary 26, 2025
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
LeadershipBayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
By Fortune EditorsFebruary 26, 2025
Robert F. Kennedy Jr.
HealthWith RFK Jr. in charge, supplement makers see chance to cash in
By KFF Health News and Arthur AllenFebruary 25, 2025
Semaglutide medications Wegovy and Ozempic are pictured
HealthWegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By Bloomberg, Madison Muller, Ike Swetlitz and Naomi KresgeFebruary 21, 2025
United States President Donald J. Trump speaks at the Friends of Ireland luncheon hosted by United States Speaker of the House of Representatives Paul Ryan, Republican of Wisconsin, at the United States Capitol March 15, 2018 in Washington, DC.
FinanceWeight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By Ryan HoggFebruary 19, 2025
A woman holds a medicine bottle while reading instructions.
HealthGen Z’s expensive drug habit: More want brand-name meds that are 79% more expensive
By Lindsey LeakeFebruary 14, 2025
Hens at a poultry farm
HealthExperts sound the alarm as Ohio farmworker’s bird flu sparks fear it’s the next pandemic
By Lindsey LeakeFebruary 13, 2025
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...100
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.